Triferic FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved January 23, 2015)
Brand name: Triferic
Generic name: ferric pyrophosphate citrate
Company: Rockwell Medical, Inc.
Treatment for: Anemia Associated with Chronic Renal Failure
Triferic (ferric pyrophosphate citrate) is an iron-replacement drug for treating iron deficiency in chronic kidney disease patients receiving hemodialysis.
Development Timeline for Triferic
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.